Ashton Thomas Private Wealth, LLC Ligand Pharmaceuticals Inc Transaction History
Ashton Thomas Private Wealth, LLC
- $2.57 Trillion
- Q4 2024
A detailed history of Ashton Thomas Private Wealth, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 1,947 shares of LGND stock, worth $233,640. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,947Holding current value
$233,640% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding LGND
# of Institutions
274Shares Held
18.5MCall Options Held
30.8KPut Options Held
5.2K-
Black Rock Inc. New York, NY2.87MShares$345 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$250 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.02MShares$122 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$106 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$89.2 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.03B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...